Director Kathy L. Hibbs of SOPHiA GENETICS SA filed a Form 4 on August 26, 2026, disclosing the sale of 6,250 ordinary shares on August 25, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Kathy L. Hibbs, identified as a Director of SOPHiA GENETICS SA (NASDAQ:SOPH)
  • Shares sold: 6,250 ordinary shares disposed of on August 25, 2026, with transaction code "S"
  • Weighted average price: $8.6773 per share, with individual transactions ranging from $8.31 to $8.83 inclusive
  • Post-transaction ownership: 103,242 ordinary shares held directly following the reported transaction
  • Rule 10b5-1 plan: The sale was made pursuant to a duly adopted trading plan under Rule 10b5-1(c)

Kathy L. Hibbs Share Sale Details and Remaining Ownership

According to the filing, Kathy L. Hibbs, a Director at SOPHiA GENETICS SA (NASDAQ:SOPH), disposed of 6,250 ordinary shares on August 25, 2026. The transaction was reported at a weighted average price of $8.6773 per share. The filing notes that the shares were sold in multiple transactions at prices ranging from $8.31 to $8.83 inclusive, and that Hibbs will provide full information regarding the number of shares sold at each separate price upon written request to the issuer, any security holder, or the SEC staff.

The filing indicates the transaction was carried out under a duly adopted trading plan that satisfies the affirmative defense conditions of Rule 10b5-1(c). Following the reported sale, Hibbs beneficially owns 103,242 ordinary shares directly. No derivative securities transactions were reported in the filing. The Form 4 was signed on August 26, 2026, by Elimara Brunetto as Attorney-in-Fact for Kathy L. Hibbs.

What Was Disclosed

The filing discloses a single sale of 6,250 ordinary shares of SOPHiA GENETICS SA by Director Kathy L. Hibbs on August 25, 2026, at a weighted average price of $8.6773, executed under a Rule 10b5-1(c) trading plan, leaving her with 103,242 directly held shares.